<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Samsung Biologics, Amgen and Biocon invest in US pharma sites — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Samsung Biologics, Amgen and Biocon invest in US pharma sites</h2>
    <div class="badge">2025-09-15T12:14:00+00:00</div>
    <ul>
      <li>Prior to that, it landed a $1.2 billion manufacturing contract with an Asia-based pharmaceutical company in October 2024.</li>
<li>The company said it has invested more than $40 billion in manufacturing and R&amp;D since the passage of the Tax Cuts and Jobs Act of 2017.</li>
<li>Amgen designated about $5 billion for U.S.</li>
<li>In April, Samsung Biologics inked a separate $514 million deal with an undisclosed U.S.</li>
<li>In 2020, Samsung Biologics opened a laboratory in San Francisco and continues to weigh U.S.</li>
<li>It is the second-biggest since the company’s founding in 2011, Korea JoongAng Daily reported.</li>
<li>pharma South Korea-based Samsung Biologics has struck a nearly $1.3 billion supplier deal with an undisclosed U.S.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Samsung%20Biologics%2C%20Amgen%20and%20Biocon%20invest%20in%20US%20pharma%20sites%0A%E2%80%A2%20Prior%20to%20that%2C%20it%20landed%20a%20%241.2%20billion%20manufacturing%20contract%20with%20an%20Asia-based%20pharmaceutical%20company%20in%20October%202024.%0A%E2%80%A2%20The%20company%20said%20it%20has%20invested%20more%20than%20%2440%20billion%20in%20manufacturing%20and%20R%26D%20since%20the%20passage%20of%20the%20Tax%20Cuts%20and%20Jobs%20Act%20of%202017.%0A%E2%80%A2%20Amgen%20designated%20about%20%245%20billion%20for%20U.S.%0A%E2%80%A2%20In%20April%2C%20Samsung%20Biologics%20inked%20a%20separate%20%24514%20million%20deal%20with%20an%20undisclosed%20U.S.%0A%E2%80%A2%20In%202020%2C%20Samsung%20Biologics%20opened%20a%20laboratory%20in%20San%20Francisco%20and%20continues%20to%20weigh%20U.S.%0A%E2%80%A2%20It%20is%20the%20second-biggest%20since%20the%20company%E2%80%99s%20founding%20in%202011%2C%20Korea%20JoongAng%20Daily%20reported.%0A%E2%80%A2%20pharma%20South%20Korea-based%20Samsung%20Biologics%20has%20struck%20a%20nearly%20%241.3%20billion%20supplier%20deal%20with%20an%20undisclosed%20U.S.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fsamsung-biologics-amgen-and-biocon-invest-in-us-pharma-sites%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/m/e5f25881-fff5-3199-870d-760af03a56cc/samsung-biologics%2C-amgen-and.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>